EJCTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colquhoun, I. W.
Right arrow Articles by Wheatley, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colquhoun, I. W.
Right arrow Articles by Wheatley, D. J.

European Journal of Cardio-Thoracic Surgery, Vol 7, 520-523, Copyright © 1993 by European Association for Cardio-thoracic Surgery


ARTICLES

Arrhythmia prophylaxis after coronary artery surgery. A randomised controlled trial of intravenous magnesium chloride

IW Colquhoun, GA Berg, M el-Fiky, A Hurle, GS Fell and DJ Wheatley
University Department of Cardiac Surgery, Glasgow Royal Infirmary, UK.

One hundred and thirty patients undergoing elective myocardial revascularisation were randomised to receive an intravenous infusion containing either 50 mmol magnesium chloride or placebo during the first 48 h following surgery. Magnesium was given to 66 patients and a placebo infusion to 64 patients. Postoperative serum magnesium concentrations fell in the placebo group (from 0.83 +/- 0.06 to 0.79 +/- 0.11 mmol/l) but were elevated in the magnesium group (from 0.82 +/- 0.05 to 1.2 +/- 0.25 mmol/l). In total, 35 patients (26.9%) had a supraventricular arrhythmia, of which 11 were in the magnesium group (16.7%) and 24 (37.5%) in the placebo group (P = 0.013). Three patients in the magnesium group had an episode of ventricular fibrillation and three patients in the placebo group had frequent ventricular ectopics. There was one death in the magnesium group associated with a perioperative myocardial infarction. This study shows that intravenous magnesium supplements reduce the incidence of supraventricular arrhythmias following coronary artery surgery.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Dunning, T. Treasure, M. Versteegh, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery
Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 852 - 872.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. C. Burgess, M. J. Kilborn, and A. C. Keech
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis
Eur. Heart J., December 1, 2006; 27(23): 2846 - 2857.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Bradley, L. L. Creswell, C. W. Hogue Jr., A. E. Epstein, E. N. Prystowsky, and E. G. Daoud
Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest, August 1, 2005; 128(2_suppl): 39S - 47S.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Miller, E Crystal, M Garfinkle, C Lau, I Lashevsky, and S J Connolly
Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis
Heart, May 1, 2005; 91(5): 618 - 623.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. Rostron, A. Sanni, and J. Dunning
Does magnesium prophylaxis reduce the incidence of atrial fibrillation following coronary bypass surgery?
Interactive CardioVascular and Thoracic Surgery, February 1, 2005; 4(1): 52 - 58.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Kohno, T. Koyanagi, H. Kasegawa, and M. Miyazaki
Three-Day Magnesium Administration Prevents Atrial Fibrillation After Coronary Artery Bypass Grafting
Ann. Thorac. Surg., January 1, 2005; 79(1): 117 - 126.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Kaplan, M. S. Kut, U. A. Icer, and M. M. Demirtas
Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery
J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 344 - 352.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. M. Treggiari-Venzi, J.-L. Waeber, T. V. Perneger, P. M. Suter, R. Adamec, and J.-A. Romand
Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery
Br. J. Anaesth., November 1, 2000; 85(5): 690 - 695.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. M. R. Satur, S. R. Stubington, A. Jennings, K. Newton, P. G. Martin, C. Gebitekin, and D. R. Walker
Magnesium Flux During and After Open Heart Operations in Children
Ann. Thorac. Surg., April 1, 1995; 59(4): 921 - 927.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.